{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-014285","form_type":"8-K","ticker":"ELAB","cik":"0001840563","company_name":"PMGC Holdings Inc.","filed_at":"2026-02-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.487759+00:00","generated_at":"2026-05-16T03:38:42.322322+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"medium","headline":"PMGC subsidiary Northstrive grants exclusive animal-health license to Modulant Biosciences","bullets":["License covers non-human animal health (feed additives) worldwide excluding South Korea.","Modulant pays revenue share; percentages and threshold amount are redacted.","License is subject to a head license; term ends on expiration of last valid patent claim.","Modulant agrees to non-compete for myostatin/Activin-A directed products during term.","Agreement incorporates binding term sheet dated May 12, 2025, previously disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-014285","json":"https://secwatch.observer/filing/0001213900-26-014285.json","markdown":"https://secwatch.observer/filing/0001213900-26-014285.md","text":"https://secwatch.observer/filing/0001213900-26-014285.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1840563/000121390026014285/0001213900-26-014285-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1840563/000121390026014285/ea0276135-8k_pmgc.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T03:38:42.322322+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d9311445baa250f6e5c5cc6519eedc6f85680809","claim":"PMGC Holdings Inc. entered into License Agreement with Modulant Biosciences LLC (effective 2026-02-04).","evidence_excerpt":"On February 4, 2026, Northstrive Biosciences Inc., a Delaware corporation (“Northstrive Biosciences”) and wholly owned subsidiary of PMGC Holdings Inc. (“Company”), entered into the License Agreement (“License Agreement”) with Modulant Biosciences LLC (“Modulant,” and, together with Northstrive Biosciences, the “Parties”), an Indiana limited liability company.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1840563/000121390026014285/0001213900-26-014285-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"license"},{"label":"Counterparty","value":"Modulant Biosciences LLC"},{"label":"Effective","value":"2026-02-04"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}